Amphastar Pharmaceuticals
AMPH
AMPH
276 hedge funds and large institutions have $2.09B invested in Amphastar Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 97 increasing their positions, 93 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 255 → 276 (+21)
5.19% more ownership
Funds ownership: 65.5% → 70.69% (+5.2%)
4% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 93
Holders
276
Holding in Top 10
3
Calls
$3.35M
Puts
$2.18M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$36.1M | |
| 3 | +$28.5M | |
| 4 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$24.7M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$13.2M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$21.4M | |
| 3 | -$11.3M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$10.5M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$10.2M |